Part 1 of 4 in the series “Buying a California Healthcare Practice with an SBA 7(a) Loan.” Related articles: Part 2: Who Should Be the Buyer When an SBA Loan Funds a Healthcare Practice Purchase? (coming soon) · Part 3: Seller Financing in an SBA Practice Acquisition: When Will the Seller Actually Get Paid? · Part 4: After the Sale: Seller Roles, Earnouts, Leases, and Stock vs. Asset Deals in SBA-Financed Practice Acquisitions (coming soon)
A hypothetical. A physician agrees to buy a medical practice for $1.5 million. The parties agree on the price, sign a letter of intent, and start preparing for closing. Then the buyer’s SBA lender reviews the deal. Its valuation does not support the full price, the seller’s planned role after closing is not allowed, and the proposed seller note does not fit the lender’s structure. Terms the parties thought were settled now have to be renegotiated.
That outcome is common and often avoidable. When an SBA 7(a) loan funds the purchase, the lender’s rules should shape the deal from the start. They come from SBA’s lending manual, SOP 50 10 8.1, which applies to applications that receive an SBA loan number on or after October 1, 2026; earlier applications remain under version 8.0. Lenders may also add their own requirements. In practice, the lender’s approved structure, including its sources and uses of funds, becomes the template the purchase agreement must follow.
1. Will the lender finance the agreed price?
In many professional healthcare practices, much of the price reflects goodwill and expected future earnings, so the lender’s valuation and cash-flow analysis matter, especially when the practice depends on the selling clinician. Under 8.1, the lender may do its own valuation only when the business purchase price is $350,000 or less and the parties are not closely related; above that, it must obtain an independent valuation. Under 8.0, the comparable threshold was $250,000. If the price exceeds the valuation, equity must cover the difference. The lender must also show that historical cash flow can support the new debt—projections are not enough—and, for a typical first-time acquisition, the minimum debt service coverage ratio is 1.25 to 1. If much of the revenue comes from the seller’s own patient care, strong historical numbers may not carry over. Before signing, the parties should agree on what happens if the valuation comes in low, including a price adjustment, a walk-away right, or added buyer equity or qualifying seller financing (see Part 3).
2. How much must the buyer put in?
For a typical first-time acquisition, the buyer must contribute equity of at least 10% of total project costs, and that requirement cannot be reduced. Seller financing on full standby can count toward only part of it; lenders generally expect the buyer’s own cash to make up the rest. Anyone who will own 20% or more of the borrower must also personally guarantee the loan. Part 3 explains seller financing; Part 2 explains who must sign.
3. Can the seller stay involved?
Usually only in a limited way. In a typical acquisition, the seller generally may not remain as an owner, officer, or employee. A transition consulting arrangement is limited to 24 months in total. Earnouts that raise the price based on future results are not permitted. Part 4 covers these rules and the exceptions, including partial sales.
4. What happens if financing falls through?
“Approved” does not mean “funded.” Loan approval, satisfaction of conditions, readiness to fund, and simultaneous closing are four separate milestones. A buyer whose contingency ends at approval may have to close even if a later condition fails, while a seller may resist a contingency that keeps the deal open indefinitely. The agreement should allocate that risk, including a financing deadline and what happens to any deposit if closing fails.
5. What should be in place before signing?
The definitive agreement can make conformity to the lender’s written approval a condition of closing. Any change from the approved structure in the purchase agreement, seller note, or transition terms should be cleared with the lender before signing. Liens on the assets being conveyed are usually paid off or released at closing, but the right treatment depends on the structure and the lender’s collateral requirements.
SBA approval doesn’t make it a compliant healthcare deal
SBA approval does not make the deal a compliant California healthcare transaction. The parties may still need to address professional-entity ownership, licensure, payer enrollment, patient-record custody, and continuity of care (see Parts 2 and 4).
When counsel is particularly valuable
Legal advice tends to be most useful before signing a letter of intent, agreeing to seller financing, or accepting the lender’s standby or transition terms. How these rules apply depends on the practice, the parties, and the lender. No agreement can guarantee approval, funding, or closing.
Sources: SBA SOP 50 10 (versions 8.1 and 8.0) · SBA Information Notice 5000-880695
Educational information only, current as of November 2026. This article is not legal, tax, or financial advice, and reading it does not create an attorney-client relationship. The example above is hypothetical. SBA rules, lender requirements, and California and federal law change, and how they apply depends on the facts of each transaction. Buyers and sellers should consult their own counsel and confirm the current SOP version and their lender’s written conditions before relying on anything here.
Matt Kinley, Esq., LL.M. in Health Law · 180 E. Ocean Blvd., Ste. 100-J, Long Beach, CA 90802 · (562) 522-3563 · matt@kinleylawpractice.com